PubMed

Diffuse large-cell lymphoma. Part II: management.

García-Pallas MV, Betancourt-García RD, Pacheco E, Castro J, Cabanillas F.

P R Health Sci J. 2009 Mar;28(1):12-7. Review. No abstract available. PMID: 19266734 [PubMed - indexed for MEDLINE]Related articles

Diffuse large-cell lymphoma. Part I: clinical features, histology and prognosis.

Betancourt-García RD, García-Pallas MV, Pacheco E, Castro J, Cabanillas F.

P R Health Sci J. 2009 Mar;28(1):5-11. Review. No abstract available. PMID: 19266733 [PubMed - indexed for MEDLINE]Related articles

Severe anemia of rapid onset in an inmunocompromised host.

Rivera Rodríguez E, Cabanillas F.

Bol Asoc Med P R. 2008 Jul-Sep;100(3):42-6.PMID: 19227716 [PubMed - indexed for MEDLINE]Related articles

Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.

Esmaeli B, McLaughlin P, Pro B, Samaniego F, Gayed I, Hagemeister F, Romaguera J, Cabanillas F, Neelapu SS, Banay R, Fayad L, Wayne Saville M, Kwak LW.

Ann Oncol. 2009 Apr;20(4):709-14. Epub 2009 Jan 15.PMID: 19150940 [PubMed - indexed for MEDLINE]Related articles

Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.

Wang M, Fayad L, Cabanillas F, Hagemeister F, McLaughlin P, Rodriguez MA, Kwak LW, Zhou Y, Kantarjian H, Romaguera J.

Cancer. 2008 Nov 15;113(10):2734-41.PMID: 18973182 [PubMed - indexed for MEDLINE]Related articlesFree article

The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.

Overman MJ, Feng L, Pro B, McLaughlin P, Hess M, Samaniego F, Younes A, Romaguera JE, Hagemeister FB, Kwak L, Cabanillas F, Rodriguez MA, Fayad LE.

Ann Oncol. 2008 Mar;19(3):553-9. Epub 2007 Dec 13.PMID: 18083690 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose dense CHOP: when more is not always better!

Cabanillas F.

Leuk Lymphoma. 2007 May;48(5):845-6. No abstract available. PMID: 17487722 [PubMed - indexed for MEDLINE]Related articles

Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma.

Berrios-Rivera JP, Fang S, Cabanillas ME, Cabanillas F, Lu H, Du XL.

Am J Clin Oncol. 2007 Apr;30(2):163-71.PMID: 17414466 [PubMed - indexed for MEDLINE]Related articles

A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma.

Lim ST, Fayad L, Tulpule A, Modiano M, Cabanillas F, Laffranchi B, Allievi C, Bernareggi A, Levine AM.

Leuk Lymphoma. 2007 Feb;48(2):374-80.PMID: 17325899 [PubMed - indexed for MEDLINE]Related articles

Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.

Pro B, Hagemeister FB, McLaughlin P, Romaguera J, Rodriguez MA, Cabanillas F, Tiongson LP, Younes A.

Leuk Lymphoma. 2006 Sep;47(9):1818-21.PMID: 17064994 [PubMed - indexed for MEDLINE]Related articles

High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication.

Cabanillas F, Liboy I, Pavia O, Rivera E.

Ann Oncol. 2006 Sep;17(9):1424-7.PMID: 16966368 [PubMed - indexed for MEDLINE]Related articlesFree article

Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.

Visco C, Nadali G, Vassilakopoulos TP, Bonfante V, Viviani S, Gianni AM, Federico M, Luminari S, Peethambaram P, Witzig TE, Pangalis G, Cabanillas F, Medeiros LJ, Sarris AH, Pizzolo G.

Eur J Haematol. 2006 Nov;77(5):387-94. Epub 2006 Jul 27.PMID: 16879607 [PubMed - indexed for MEDLINE]Related articles

Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.

Liu Q, Fayad L, Cabanillas F, Hagemeister FB, Ayers GD, Hess M, Romaguera J, Rodriguez MA, Tsimberidou AM, Verstovsek S, Younes A, Pro B, Lee MS, Ayala A, McLaughlin P.

J Clin Oncol. 2006 Apr 1;24(10):1582-9.PMID: 16575009 [PubMed - indexed for MEDLINE]Related articles

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.

Zelenetz AD, Advani RH, Buadi F, Cabanillas F, Caligiuri MA, Czuczman MS, Damon LE, Fayad L, Flinn IW, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Kaminski MS, Lacasce AS, Nademanee A, Porcu P, Press O, Prosnitz L, Smith MR, Sotomayor EM, Vose JM, Yahalom J; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Mar;4(3):258-310. No abstract available. PMID: 16507273 [PubMed - indexed for MEDLINE]Related articles

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.

Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S, Wierda WG, Pierce SA, Shan J, Brandt M, Hagemeister FB, Keating MJ, Cabanillas F, Kantarjian H.

Cancer. 2006 Apr 1;106(7):1569-80.PMID: 16502413 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.

Thomas DA, Sarris AH, Cortes J, Faderl S, O'Brien S, Giles FJ, Garcia-Manero G, Rodriguez MA, Cabanillas F, Kantarjian H.

Cancer. 2006 Jan 1;106(1):120-7. Erratum in: Cancer. 2006 Apr 1;106(7):1641. PMID: 16331634 [PubMed - indexed for MEDLINE]Related articlesFree article

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.

Romaguera JE, Fayad L, Rodriguez MA, Broglio KR, Hagemeister FB, Pro B, McLaughlin P, Younes A, Samaniego F, Goy A, Sarris AH, Dang NH, Wang M, Beasley V, Medeiros LJ, Katz RL, Gagneja H, Samuels BI, Smith TL, Cabanillas FF.

J Clin Oncol. 2005 Oct 1;23(28):7013-23. Epub 2005 Sep 6. Erratum in: J Clin Oncol. 2006 Feb 1;24(4):724. PMID: 16145068 [PubMed - indexed for MEDLINE]Related articles

A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.

Ha CS, Cabanillas F, Lee MS, Tucker SL, McLaughlin P, Rodriguez MA, Younes A, Romaguera JE, Mesina OM, Cox JD.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):188-93.PMID: 16111588 [PubMed - indexed for MEDLINE]Related articles

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.

Tsimberidou AM, Younes A, Romaguera J, Hagemeister FB, Rodriguez MA, Feng L, Ayala A, Smith TL, Cabanillas F, McLaughlin P.

Cancer. 2005 Jul 15;104(2):345-53.PMID: 15948158 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of mitoxantrone in the treatment of indolent lymphomas.

Hagemeister F, Cabanillas F, Coleman M, Gregory SA, Zinzani PL.

Oncologist. 2005 Feb;10(2):150-9. Review.PMID: 15709217 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.

Goy A, Younes A, McLaughlin P, Pro B, Romaguera JE, Hagemeister F, Fayad L, Dang NH, Samaniego F, Wang M, Broglio K, Samuels B, Gilles F, Sarris AH, Hart S, Trehu E, Schenkein D, Cabanillas F, Rodriguez AM.

J Clin Oncol. 2005 Feb 1;23(4):667-75. Epub 2004 Dec 21.PMID: 15613697 [PubMed - indexed for MEDLINE]Related articles

Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.

Visco C, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Medeiros LJ, Notti P, Rassidakis GZ, Peethambaram P, Wilder R, Witzig T, Gianni M, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH.

Leuk Lymphoma. 2004 Oct;45(10):2085-92.PMID: 15370254 [PubMed - indexed for MEDLINE]Related articles

Establishment and characterization of a new mantle cell lymphoma cell line M-1.

Goy A, Remache YK, Gu J, Stewart J, Hayes KJ, Gold D, Jiang Y, Barkoh BA, Katz R, Cabanillas F, Gilles F.

Leuk Lymphoma. 2004 Jun;45(6):1255-60.PMID: 15360009 [PubMed - indexed for MEDLINE]Related articles

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.

Younes A, Pro B, Robertson MJ, Flinn IW, Romaguera JE, Hagemeister F, Dang NH, Fiumara P, Loyer EM, Cabanillas FF, McLaughlin PW, Rodriguez MA, Samaniego F.

Clin Cancer Res. 2004 Aug 15;10(16):5432-8.PMID: 15328181 [PubMed - indexed for MEDLINE]Related articlesFree article

Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma.

Thomas DA, O'Brien S, Cortes J, Giles FJ, Faderl S, Verstovsek S, Ferrajoli A, Koller C, Beran M, Pierce S, Ha CS, Cabanillas F, Keating MJ, Kantarjian H.

Blood. 2004 Sep 15;104(6):1624-30. Epub 2004 Jun 3.PMID: 15178574 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.

Popat U, Hosing C, Saliba RM, Anderlini P, van Besien K, Przepiorka D, Khouri IF, Gajewski J, Claxton D, Giralt S, Rodriguez M, Romaguera J, Hagemeister F, Ha C, Cox J, Cabanillas F, Andersson BS, Champlin RE.

Bone Marrow Transplant. 2004 May;33(10):1015-23.PMID: 15048145 [PubMed - indexed for MEDLINE]Related articles

Thalidomide for patients with recurrent lymphoma.

Pro B, Younes A, Albitar M, Dang NH, Samaniego F, Romaguera J, McLaughlin P, Hagemeister FB, Rodriguez MA, Clemons M, Cabanillas F.

Cancer. 2004 Mar 15;100(6):1186-9.PMID: 15022285 [PubMed - indexed for MEDLINE]Related articlesFree article

Quantitative assessment of disease involvement by follicular lymphoma using real-time polymerase chain reaction measurement of t(14;18)-carrying cells.

Lee WI, Cabanillas F, Lee MS.

Int J Hematol. 2004 Feb;79(2):152-6.PMID: 15005343 [PubMed - indexed for MEDLINE]Related articles

Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).

Ha CS, Lee MS, McLaughlin P, Tucker SL, Wilder RB, Cox JD, Cabanillas F.

Cancer J. 2004 Jan-Feb;10(1):49-53.PMID: 15000495 [PubMed - indexed for MEDLINE]Related articles

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB).

Mendez A, Cabanillas F, Echenique M, Malekshamran K, Perez I, Ramos E.

Ann Oncol. 2004 Mar;15(3):450-4. Review.PMID: 14998847 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.

Mendez A, Cabanillas F, Echenique M, Malekshamran K, Perez I, Ramos E.

Cancer. 2004 Feb 15;100(4):710-4.PMID: 14770425 [PubMed - indexed for MEDLINE]Related articlesFree article

Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.

Chronowski GM, Wilder RB, Levy LB, Atkinson EN, Ha CS, Hagemeister FB, Barista I, Rodriguez MA, Sarris AH, Hess MA, Cabanillas F, Cox JD.

Am J Clin Oncol. 2004 Feb;27(1):73-80.PMID: 14758137 [PubMed - indexed for MEDLINE]Related articles

Stage III follicular lymphoma: long-term follow-up and patterns of failure.

Ha CS, Kong JS, McLaughlin P, Tucker SL, Fayad LE, Hess MA, Wilder RB, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):748-54.PMID: 14529780 [PubMed - indexed for MEDLINE]Related articles

Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma.

Dabaja BS, Ha CS, Wilder RB, Pro B, McLaughlin P, Cabanillas F, Cox JD.

Cancer J. 2003 Jul-Aug;9(4):321-4.PMID: 12967143 [PubMed - indexed for MEDLINE]Related articles

Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.

Ha CS, Kong JS, Tucker SL, McLaughlin P, Wilder RB, Hess MA, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):316-20.PMID: 12957240 [PubMed - indexed for MEDLINE]Related articles

Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.

Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD.

Cancer. 2003 Sep 1;98(5):1021-8.PMID: 12942571 [PubMed - indexed for MEDLINE]Related articlesFree article

Establishment and characterization by gene expression profiling of a new diffuse large B-cell lymphoma cell line, EJ-1, carrying t(14;18) and t(8;14) translocations.

Goy A, Ramdas L, Remache YK, Gu J, Fayad L, Hayes KJ, Coombes KR, Barkoh BA, Katz R, Ford R, Cabanillas F, Gilles F.

Lab Invest. 2003 Jun;83(6):913-6. No abstract available. PMID: 12808126 [PubMed - indexed for MEDLINE]Related articles

Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.

Rassidakis GZ, Goy A, Medeiros LJ, Jiang Y, Thomaides A, Remache Y, Cabanillas F, Sarris AH, Gilles F.

Clin Cancer Res. 2003 Jun;9(6):2213-20.PMID: 12796388 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.

Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH.

Clin Cancer Res. 2003 Jun;9(6):2114-20.PMID: 12796376 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.

Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P.

J Clin Oncol. 2003 Jun 1;21(11):2115-22. Review.PMID: 12775737 [PubMed - indexed for MEDLINE]Related articles

Asymptomatic Waldenstrom's macroglobulinemia.

Alexanian R, Weber D, Delasalle K, Cabanillas F, Dimopoulos M.

Semin Oncol. 2003 Apr;30(2):206-10.PMID: 12720137 [PubMed - indexed for MEDLINE]Related articles

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.

Hosing C, Saliba RM, McLaughlin P, Andersson B, Rodriguez MA, Fayad L, Cabanillas F, Champlin RE, Khouri IF.

Ann Oncol. 2003 May;14(5):737-44.PMID: 12702528 [PubMed - indexed for MEDLINE]Related articlesFree article

Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas.

Lee HK, Wilder RB, Jones D, Ha CS, Pro B, Rodriguez MA, Romaguera JE, Cabanillas F, Rodriguez J, Cox JD.

Leuk Lymphoma. 2002 Sep;43(9):1769-75.PMID: 12685830 [PubMed - indexed for MEDLINE]Related articles

Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.

Romaguera JE, Medeiros LJ, Hagemeister FB, Fayad LE, Rodriguez MA, Pro B, Younes A, McLaughlin P, Goy A, Sarris AH, Dang NH, Samaniego F, Brown HM, Gagneja HK, Cabanillas F.

Cancer. 2003 Feb 1;97(3):586-91. Erratum in: Cancer. 2003 Jun 15;97(12):3131. PMID: 12548600 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic abnormalities in lymphoma.

Cabanillas F.

Clin Lymphoma. 2002 Dec;3 Suppl 1:S32-6.PMID: 12521387 [PubMed - indexed for MEDLINE]Related articles

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):36-43.PMID: 12504034 [PubMed - indexed for MEDLINE]Related articles

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.

Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB, Barista I, Hess MA, Cabanillas F, Cox JD.

Cancer. 2002 Dec 15;95(12):2534-8.PMID: 12467067 [PubMed - indexed for MEDLINE]Related articlesFree article

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.

Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Viviani S, Bonfante V, Nadali G, Herling M, Angelopoulou MK, Giardini R, Chilosi M, Kittas C, McDonnell TJ, Bonadonna G, Gianni AM, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH.

Blood. 2002 Dec 1;100(12):3935-41.PMID: 12433696 [PubMed - indexed for MEDLINE]Related articlesFree article

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.

Schlembach PJ, Wilder RB, Jones D, Ha CS, Fayad LE, Younes A, Hagemeister F, Hess M, Cabanillas F, Cox JD.

Cancer J. 2002 Sep-Oct;8(5):377-83.PMID: 12416895 [PubMed - indexed for MEDLINE]Related articles

Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.

Tsimberidou AM, Jiang Y, Ford RJ, Lichtiger B, Medeiros LJ, McLaughlin P, Cabanillas F, Sarris AH.

Leuk Lymphoma. 2002 Aug;43(8):1589-98.PMID: 12400601 [PubMed - indexed for MEDLINE]Related articles